NeuroSigma
PrivateLast Round
Corporate Funding
Dec 15, 2025
Total Funding Raised
$9.6M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
NeuroSigma is a bioelectronic medical device company that develops and commercializes non-invasive trigeminal nerve stimulation (TNS) technologies for treating disorders such as pediatric ADHD, epilepsy, and depression.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Mental Health
Business Model
B2B
Customer Profile
Hardware + Subscription, Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NeuroSigma Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
NeuroSigma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Corporate Funding | Dec 15, 2025 | ||||
| Debt Conversion | Dec 8, 2021 | ||||
| Corporate Funding | Dec 8, 2021 | ||||
| Corporate Funding | Sep 21, 2020 | ||||
| Grant | Feb 4, 2013 |
NeuroSigma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| National Institute of Neurological Disorders and Stroke (NINDS) | Grant |
| Checkmate Capital | Corporate Funding |
| National Institute of Neurological Disorders and Stroke | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 22, 2026
Monthly visitors grew 115% MoM, reaching 4K.
- Dec 15, 2025
$1M raised in corporate funding.
NeuroSigma Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about NeuroSigma's valuation, stock price, and market status.